Turkey is a leading destination for leukemia treatment, with hospitals like Anadolu Medical Center, Memorial Şişli Hospital, and Memorial Bahçelievler Hospital accredited by the Joint Commission International. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, is among the top 10 hospitals globally for medical tourism. Memorial Şişli Hospital, the first in Turkey with JCI accreditation, has a 90% success rate in organ transplants and expertise in bone marrow transplants. Memorial Bahçelievler Hospital offers specialized oncological treatments.
Turkey provides advanced leukemia treatments, including CAR T-cell therapy, targeted therapy, monoclonal antibody therapy, and stem cell transplantation. These treatments have improved survival rates, with a 5-year leukemia survival rate in Turkey reaching over 93%. This reflects Turkey's commitment to state-of-the-art medical practices and technologies.